Breakthrough mjn-SERAS crisis monitoring device that uses artificial intelligence to predict and alert of impending UK crisis launches


Epilepsy Alarms UK is proud to bring the mjn-SERAS to the UK – a revolutionary device that uses artificial intelligence to predict seizures with up to 3 minutes of advanced warning.

With European CE marking as a medical device*, the mjn-SERAS revolutionizes seizure detection. Designed and manufactured by Spanish start-up mjn-NEURO, the device strays from the trend of wrist-worn seizure monitors and instead consists of a 3D-printed earpiece that custom-fits to each user to maximize comfort. With an impressive battery life of up to 18 hours, the mjn-SERAS has been designed to be light and discreet and weighs only 9.5g.

The mjn-SERAS houses sensors that directly monitor electrical activity in the brain and use artificial intelligence to warn of a seizure up to 3 minutes before an episode occurs.

Powered by artificial intelligence, the device uses machine learning to customize the algorithm based on the user’s brain activity patterns, improving its ability to predict future seizures.

When a seizure is predicted, the device sends an alert to the paired Android smartphone, giving the user time to ensure they can get to a safe place and notify loved ones of their impending episode.

Users can also choose to automatically share crisis alerts with others, reassuring caregivers or loved ones who are worried about the risks of an unmonitored episode.

The mjn-SERAS can also be used by professionals to better understand a patient’s condition. Data is stored on the paired smartphone as a timeline and graph for easy visualization of patterns that doctors and neurologists can use to tailor treatment to the patient.

The mjn-SERAS will be available for purchase in the UK exclusively from Epilepsy Alarms UK from £1,495. We are also proud to announce that all purchases will support Young Epilepsy, a UK charity which does amazing work helping people with epilepsy to live better lives.

*According to European Directive 93/42/EEC and Royal Decree RD. 1591/2009

“What I really like about mjn-SERAS isn’t just about reacting to someone having a seizure, it’s also telling you that a seizure might be happening – that’s pretty groundbreaking. Technology is changing so fast and improving all the time. A I hope that ultimately the NHS can consider using the mjn-SERAS and similar devices on their free drug tariff. The more people managing their own conditions, the less impact there is on the NHS. – Dr Hilary Jones MBE, popular GP and TV personality

press contact

For any questions regarding the launch of mjn-SERAS in the UK or for a press kit containing information and images approved for reuse, please contact the Epilepsy Alarms UK marketing team at [email protected]

For any sales-related inquiries or to discuss the suitability of mjn-SERAS for you, a patient or loved one, please visit or contact [email protected]

Media Contact
Company Name: Epilepsy Alarms UK
Contact person: Stuart Smith
Country: UK


About Author

Comments are closed.